Collagen and Other Injectable Fillers 

  • Author: Ashok Tholpady, MD, MSc; Chief Editor: Deepak Narayan, MD, FRCS   more...
 
Updated: Jul 11, 2011
 

Background

Over the past 30 years, the methods available for the removal or improvement of acne scars and for the correction of wrinkle lines increased exponentially with the advent of new skin filler substances, improved techniques for elevating existing scars, and technology for abrading and resurfacing facial contours. Seemingly every month, a new and improved filling agent or laser, which will be the best of all available methods, becomes available. In the midst of these technological breakthroughs, the basic mechanisms remain the same. Three categories of techniques are presently available to improve acne scars: (1) scar removal and revision; (2) filling depressed scars; and (3) contouring the surface of scars.

Before and after images are below.

Photograph before collagen injection. Photograph before collagen injection. Photograph after collagen injection. Photograph after collagen injection.
Next

History of the Procedure

The goal for research and development in this field over the past 50 years has been the synthesis of the ideal filler substance for skin and soft-tissue augmentation. The ideal filling material has the following qualities:

  • Physiologic - Incorporates itself with the body's tissues
  • Simple procedure - Injectable
  • Risk free - No complications or adverse effects
  • Permanent - Does not degrade with time

This ideal has not been met but it has been the goal in creating all presently available materials.

Physiologic filling materials such as dermis, fascia, and fat have been used as autologous implants for many years, with specific surgical techniques used for each. These remain in use today but on the whole are cumbersome and complicated surgical operations with associated adverse effects and complications. Injectable filling materials included cutting oils, paraffin, and silicone, each with its own adverse effects and complications.

The first Food and Drug Administration (FDA)-approved injectable filling agent, bovine collagen, was approved in 1982 and remains the most commonly used product for skin and soft-tissue augmentation. In fact, Zyderm remains the criterion standard against which all new fillers are compared.

Thirty years ago, one either excised a scar or dermabraded the surface. Combinations of these two methods were beginning along with punch grafts and the use of autodermal grafts. The basic workup and evaluation of these scars remain essentially the same because these choices are available for the types of scars the clinician evaluates for improvement. This review discusses skin-filling agents available for scar correction.

Previous
Next

Problem

Distensible cutaneous scars are best elevated with filling material. A distensible scar is defined as one that elevates to the surface when tension is placed on either side. This simple test allows the clinician to determine whether a particular scar is likely to respond to filling material. Fibrotic ice pick and fixed scars cannot be elevated because the scar tissue extends through to the subcutaneous tissue plane. Placing filling material in the dermis only elevates the surrounding skin and produces a donut effect, making the scar appear worse.

The ideal skin-filling agent is safe, physiologic, simple, and permanent. No known substance meets all of these criteria. Each of the available substances has adverse effects that detract from these properties, but all are the result of striving to perfect their qualities to fulfill these requirements. The list of injectable filling materials increases each month, with both synthetic and natural substances added. Other implant materials may be placed surgically.

Previous
Next

Indications

Indications for collagen injection are acne scars, traumatic scars, photoaging, wrinkles, and gravitational rhytides.

Previous
Next

Contraindications

Contraindications to this procedure include allergy to bovine collagen, allergy to lidocaine, pregnancy, or a collagen vascular disease such as dermatomyositis or polymyositis.

Previous
 
 
Contributor Information and Disclosures
Author

Ashok Tholpady, MD, MSc  Resident Physician, Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston

Ashok Tholpady, MD, MSc is a member of the following medical societies: Academy of Clinical Laboratory Physicians and Scientists, American Society for Clinical Pathology, College of American Pathologists, Harris County Medical Society, and United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.

Coauthor(s)

Thomas J Gampper, MD  Vice Chair, Department of Surgery, Director of Aesthetic and Laser Surgery, Associate Professor, Departments of Plastic Surgery and Clinical Neurosurgery, University of Virginia

Thomas J Gampper, MD is a member of the following medical societies: American Association of Plastic Surgeons, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Society for Aesthetic Plastic Surgery, American Society for Laser Medicine and Surgery, American Society of Plastic Surgeons, Association of Academic Chairmen of Plastic Surgery, and Undersea and Hyperbaric Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Rodrigo Santamarina, MD  Attending Plastic Surgeon, Berkshire Medical Center; Clinical Assistant Professor of Surgery, Plastic and Hand Surgeon, Division of Plastic Surgery, University of Massachusetts Medical School

Rodrigo Santamarina, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, Massachusetts Medical Society, New York Academy of Sciences, and Society of American Gastrointestinal and Endoscopic Surgeons

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Mark E Krugman, MD  Assistant Professor of Plastic Surgery and Clinical Professor of Otolaryngology-Head and Neck Surgery, University of California at Irvine School of Medicine

Mark E Krugman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American College of Surgeons, American Society for Aesthetic Plastic Surgery, American Society for Laser Medicine and Surgery, and American Society of Plastic and Reconstructive Surgery

Disclosure: Nothing to disclose.

Nicolas (Nick) G Slenkovich, MD  Director, Colorado Plastic Surgery Center

Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, and Colorado Medical Society

Disclosure: Nothing to disclose.

Chief Editor

Deepak Narayan, MD, FRCS  Associate Professor of Surgery (Plastic), Yale University School of Medicine; Chief of Plastic Surgery, West Haven Veterans Affairs Medical Center

Deepak Narayan, MD, FRCS is a member of the following medical societies: American Association for the Advancement of Science, American College of Surgeons, American Medical Association, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, Indian Medical Association, Plastic Surgery Research Council, Royal College of Surgeons of Edinburgh, and Royal College of Surgeons of England

Disclosure: Nothing to disclose.

References
  1. Hilinski JM, Cohen SR. Soft tissue augmentation with ArteFill. Facial Plast Surg. May 2009;25(2):114-9. [Medline].

  2. azficel-T (laViv) [package insert]. Fibrocell Science, Inc; 2011. [Full Text].

  3. Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg. May 2009;25(2):95-9. [Medline].

  4. Hornberger J, Rajagopalan R, Shewade A, Loutfy MR. Cost consequences of HIV-associated lipoatrophy. AIDS Care. May 2009;21(5):664-71. [Medline].

  5. Matarasso SL. Injectable collagens: lost but not forgotten--a review of products, indications, and injection techniques. Plast Reconstr Surg. Nov 2007;120(6 Suppl):17S-26S. [Medline].

  6. Duffy DM. Understanding sclerotherapy. In: Principles and Techniques of Cutaneous Surgery. Columbus, Ohio: McGraw-Hill; 1996:403-417.

  7. Elson ML. Evaluation and Treatment of the Aging Face. Springer-Verlag; 1995.

  8. Klein AW. Skin Filling Agents. 1997.

  9. Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and Techniques. New York: Marcel Dekker; 1998.

  10. Melton JL, Hanke CW. Soft tissue augmentation. In: Roenigk RK, Roenigk HHR. Dermatologic Surgery. 2nd ed. New York: Marcel Dekker; 1996.

  11. Monheit GD. Injection techniques in cutaneous scars for soft tissue augmentation. Cosmetic Dermatology. 1992;5(4):10-15.

  12. Swinehart JM. Dermal grafting. In: Klein AW, ed. Tissue Augmentation in Clinical Practice: Procedures and Techniques. New York: Marcel Dekker; 1998:63-95.

Previous
Next
 
Photograph before collagen injection.
Photograph after collagen injection.
Photograph before collagen injection.
Photograph after collagen injection.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.